Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today provided a corporate update and reported ...

Tumor necrosis factor-α-induced protein-8 like-2 suppressed the proliferation, migration, and invasion of cholangiocarcinoma cells.

PLN-101095 Phase 1 data showed deep and durable ongoing responses in checkpoint inhibitor refractory solid tumors PLN-101095 accelerated development plan underway with initiation of Phase 1b indicatio ...

如今，许多癌症患者拥有比过去更多的治疗选择。然而，对于某些癌症，如胰腺癌，手术和化疗仍然是仅有的可用疗法。加州大学圣地亚哥分校的癌症生物学家Tatiana Hurtado de ...

纤维连接蛋白作为细胞外基质的核心组分之一，其表达调控机制与细胞骨架动态重组之间存在何种分子关联，这一问题在既往研究中尚未得到充分阐明。近期一项整合动物模型与体外细胞学实验的研究，系统揭示了Cdc42效应蛋白家族成员Cdc42ep1在TGF-β诱导的上皮 ...

Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through a specific signaling pathway in ...

New UAB research uncovers how NFAT helps uterine NK cells support early placenta development, shedding light on pregnancy health and the roots of complications like preeclampsia.

FAYETTEVILLE, GA, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- Chronic diabetic wounds fail to heal because ...

Macrophages are central to mechanobiology research: their physical characteristics-stiffness, adhesion, and ECM (extracellular matrix) sensing-are inextricably linked to their phenotypic polarization ...

Presented data at ESMO 2025 demonstrating promising efficacy with CRB-701 in head and neck squamous cell carcinoma (HNSCC) ...

Thomas Smith Leerink Partners LLC, Research Division. Good morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name is Tom Smith ...

The table below is a review of notable updates that occurred in February 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.